Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism

New Microbiologica

Volumn 26, Issue 4, 2003, Pages 375-381

  Piana, A ^a   Orru M ^a   Masia, M D ^a   Sotgiu, G ^a   Muresu, E ^a   Maida, A ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Drug resistance; Isoniazid and rifampin resistance; Mycobacterium tuberculosis; PCR RFLP; PCR SSCP; Point mutations

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; GENE MUTATION; MOLECULAR DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; DRUG EFFECT; GENETICS; HUMAN; POINT MUTATION; SENSITIVITY AND SPECIFICITY;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RIFAMPIN; SENSITIVITY AND SPECIFICITY;

EID: 0642311328     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BANERJEE, A., DUBNAU, E., QUEMARD, A., BALASUBRAMANIAN, V., UM, S.K., WILSON, T., COLLINS, D., DE LISLE, G., and JACOBS, W.R. (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosi. Science, 263, 227-230.
2. COLE, S.T. (1994). Mycobacterium tuberculosis: drug resistance mechanisms. Trends in Microbiology, 2, 411-415.
3. DERETIC, V., PHILIPP, W., DHANDAYUTHAPANI, S., MUDD, M.H., CURCIC, R., GARBE, T., HEYM, B., VIA, L.E., and COLE, S.T. (1995). Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Molecular Microbiology, 17, 889-900.
4. EISENACH, K.D., CAVE, M.D., BATES, J.H., and CRAWFORD, J.T. (1989). Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. Journal of Infectious Diseases, 161, 977-981.
5. FRANKLIN, R., and COCKERILL, III. (1999). Genetic Methods for assessing antimicrobial resistance. Antimicrobial Agents and Chemotherapy, 43, 199-212.
6. GOBLE, M., ISEMAN, M.D., and MADSEN, L.A. (1993). Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. New England Journal of Medicine, 328, 527-532.
7. HEEP, M., BRANDSTATTER, B., RIEGER, U., LEHN, N., RICHTER, E., RUSH-GERDES, S., and NIEMMAN, S. (2001). Frequency of rpoB mutations inside and outside the cluster I region in Rifampin-resistat clinical Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology, 39, 107-110.
8. HUNT, J.M., ROBERTS, G.D., STOCKMAN, L., FELMLEE, T.A., and PERSING, D.H. (1994). Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagnostic Microbiology and Infectious Diseases, 18, 219-227.
9. ISEMAN, M.D. (1993). Treatment of multidrug- resistant tuberculosis. New England Journal of Medicine, 329, 784-787.
10. KAPUR, V., LI, L.L., IORDANESCU, S., HAMRICK, M.R., WANGER, A., KREINSWIRTH, B.N., and MUSSER, J.M. (1994). Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. Journal of Clinical Microbiology, 32, 1095-1098.
11. KELLEY, C.L., ROUSE, D.A., and MORRIS, S.L. (1997). Analysis of ahpC gene mutations in isoniazid-resistan clinical isolates of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 41, 2057-2058.
12. MATSIOTA-BERNARD, P., WASER, S., TASSIOS, P.T., KYRIAKOPOULOS, A., and LEGAKIS, N.J. (1997). Rapid discrimination of Mycobacterium avium strains from AIDS patients by randomly amplified polymorphic DNA analysis. Journal of Clinical Microbiology, 35, 1585-1588.
13. MITCHINSON, D.A. (1998). How drug resistance emerges as a rsult of poor compliance during short course chemoterapy for tuberculosis. International Journal of Lung Diseases, 2, 10-15.
14. MURESU, E., PIANA, A., AZARA, A., MAIDA, I., NASTASI, A., SAJID S.D., and RUBINO, S. (2001). Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting. New Microbiologica, 24, 371-377.
15. PIANA, A., MAIDA I., SOTGIU G., SOLINAS G., ORRU M., SANTONI A., MURESU E., and MURA I. (2001). Molecular approach in the diagnosis of human tuberculosis. Annali di Igiene, 13, 101-110.
16. PIATECK, A.S., TELENTI, A., MURRAY, M.G., EL-HAJJ, H., JACOBS, W.R., KRAMER, F.R., and ALLAND, D. (2000). Genotypic analysis of of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Antimicrobial Agents and Chemotherapy, 44, 103-110.
17. RINDER, H., FELDMANN, K., TORTOLI, E., GROSSET, J., CASAL, M., RICHTER, E., RIFAI, M., JARLIER, V., VAQUERO, M., RUSCH-GERDES, S., CAMBAU, E., GUTIERREZ, J., and LOSCHER, T. (1999). Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples. Molecular Diagnosis, 4, 145-152.
18. ROSSI, G. (1999). Attualità in tema di terapia antibiotica della tubercolosi. Recenti progressi in Medicina, 90, 241-243.
19. SCARPELLINI, P., BRAGLIA, S., BRAMBILLA, A.M., DALESSANDRO, M., CICHERO, P., GORI, A., and LAZZARIN, A. (1997). Detection of Rifampin resistance by Single-Strand Conformation Polymorphism Analysis of Cerebrospinal Fluid of patients with tuberculosis of the Central Nervous System. Journal of Clinical Microbiology, 35, 2802-2806.
20. SHERMAN, D.R., SABO, P.J., HICKEY, M.J., ARAIN, T.M. MAHAIRAS, G.G., YUAN, T., BARRY, C.E., and STOVER, C.K. (1995). Disparate tresponses to oxidative stress in saprophytic and pathogenic Mycobacteria. Proceedings of the National Academy of Sciences of the United States of America, 92, 6625-6629.
21. SUMARTOJO, E. (1993). When tuberculosis treatment fails. A social behavioral account of patient adherence". American review of Respiratory Diseases, 147, 1311-1320.
22. TELENTI, A. (1997). Genetics of drug resistance in tuberculosis. Clinics in Chest Medicine, 18, 55-64.
23. TELENTI, A., HONORÉ, N., BERNASCONI, C., MARCH, J., ORTEGA, A., HEYM, B., TAKIFF, H.E., and COLE, S.T. (1997). Genotypic assessment of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. Journal of Clinical Microbiology, 35, 719-723.
24. TELENTI, A., IMBODEN, P., MARCHESI, F., LOWRIE, D., COLE, S.T., COLSTON, M.J., MATTER, L., SCHOPFER, K., and BODMER T. (1993). Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
25. TORRES, M.J., CRIADO, A., PALOMARES, J.C., and AZNAR, J. (2000). Use of Real-Time PCR and fluorimetry for rapid detection of rifampin and Isoniazid resistance-associated mutations in Mycobacterium tuberculosis. Journal of Clinical Microbiology, 38, 3194-3199.
26. WILLIAMS, D.L., WAGUESPACK, C., EISENACH, K., CRAWFORD, J.T., PORTAELS, F., SALFINGER, M., NOLAN, C.M., ABE, C., STICHT-GROH, V., and GILLIS, T.P. (1994). Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrobial Agents and Chemotherapy, 38, 2380-2386.
27. WILSON, T.M., and COLLINS, D.M. (1996). AhpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex". Molecular Microbiology, 19, 1025-1034.
28. WORLD HEALTH ORGANIZATION (1996). Treatment of tuberculosis: Guidelines for National Programmes. Geneva, Switzerland, 1996. WHO/TB/96.199.
29. ZHANG, Y., HEYM, B., ALLEN, B., YOUNG, D., and COLE, S.T. (1992). The catalase peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature, 358, 501-593.